Viloxazine was first described by 1972[10] and was marketed as an antidepressant in Europe in 1974.[6][11] It was not marketed in the United States at this time.[12] The medication was discontinued in 2002 for commercial reasons.[6][13][14] However, it was repurposed for the treatment of ADHD and was reintroduced, in the United States, in April 2021.[6][15][16] Viloxazine is a non-stimulant medication; it has no known misuse liability and is not a controlled substance.[1]
Analyses of clinical trial data suggest that viloxazine produces moderate reductions in symptoms; it is about as effective as atomoxetine and methylphenidate but with fewer side effects.[7][8][9]
Depression
Viloxazine was previously marketed as an antidepressant for the treatment of major depressive disorder.[6][5] It was considered to be effective in mild to moderate as well as severe depression with or without co-morbid symptoms.[6] The typical dose range for depression was 100 to 400mg per day in divided doses administered generally two to three times per day.[6]
Available forms
Viloxazine is available for ADHD in the form of 100, 150, and 200 mg extended-releasecapsules.[1] These capsules can be opened and sprinkled into food for easier administration.[1]
Side effects
The most common side effects include drowsiness, headache, loss of appetite. Psychiatric side effects occur in about 20% of cases; the most common of these is irritability (>5%).[17] Other common side effects include nausea, vomiting, epigastric pain, insomnia,[6] and increased libido.[18] Incidence of some side effects, including headache and drowsiness, appear to be dose-dependent.[19] In the treatment of depression, viloxazine is more tolerable than tricyclic antidepressants such as imipramine and amitryptiline.[6]
There were three cases of seizure worldwide, and most animal studies [and clinical trials that included epilepsy patients] indicated the presence of anticonvulsant properties, so viloxazine is not completely contraindicated in patients with epilepsy.[20]
Interactions
Viloxazine increased plasma levels of phenytoin by an average of 37%.[21] It also was known to significantly increase plasma levels of theophylline and decrease its clearance from the body,[22] sometimes resulting in accidental overdose of theophylline.[23]
More recent research has found that the pharmacodynamics of viloxazine may be more complex than previously assumed.[6][25] In 2020, viloxazine was reported to have significant affinity for the serotonin 5-HT2B and 5-HT2C receptors (Ki = 3,900 nM and 6,400 nM) and to act as an antagonist and agonist of these receptors, respectively.[25][5] It also showed weak antagonistic activity at the serotonin 5-HT7 receptor and the α1B- and β2-adrenergic receptors.[25][5] These actions, although relatively weak, might be involved in its effects and possibly its therapeutic effectiveness in the treatment of ADHD.[6][25]
Pharmacokinetics
Absorption
The bioavailability of extended-release viloxazine relative to an instant-release formulation was about 88%.[1]Peak and AUCTooltip area-under-the-curve (pharmacokinetics) levels of extended-release viloxazine are proportional over a dosage range of 100 to 400 mg once daily.[1] The time to peak levels is 5 hours with a range of 3 to 9 hours after a single 200 mg dose.[1] A high-fat meal modestly decreases levels of viloxazine and delays the time to peak by about 2 hours.[1]Steady-state levels of viloxazine are reached after 2 days of once-daily administration and no accumulation occurs.[1] Levels of viloxazine are approximately 40 to 50% higher in children age 6 to 11 years compared to children age 12 to 17 years.[1]
Distribution
The plasma protein binding of viloxazine is 76 to 82% over a concentration range of 0.5 to 10 μg/mL.[1]
The elimination of viloxazine is mainly renal.[1] Approximately 90% of the dose is excreted in urine within 24 hours and less than 1% of the dose is recovered in feces.[1]
The elimination half-life of instant-release viloxazine is 2 to 5 hours (2–3 hours in the most reliable studies)[2] and the half-life of extended-release viloxazine is 7.02 ± 4.74 hours.[1]
The medication was first marketed in 1974.[6][11] Viloxazine was not approved for medical use by the FDA.[12] In 1984, the FDA granted the medication an orphan designation for treatment of cataplexy and narcolepsy with the tentative brand name Catatrol.[30] For unknown reasons however, it was never approved or introduced for these uses in the United States.[6] Viloxazine was withdrawn from markets worldwide in 2002 for commercial reasons unrelated to efficacy or safety.[6][13][14]
As of 2015, Supernus Pharmaceuticals was developing extended release formulations of viloxazine as a treatment for ADHD and major depressive disorder under the names SPN-809 and SPN-812.[31][32] Viloxazine was approved for the treatment of ADHD in the United States in April 2021.[15][16]
The benefit of viloxazine was evaluated in three clinical studies, including two in children (ages 6 to 11 years) and one in adolescents (ages 12 to 17 years) with ADHD.[33] In each study, pediatric participants were randomly assigned to receive one of two doses of viloxazine or placebo once daily for 6 to 8 weeks.[33] None of the participants, their parent(s)/caregiver(s), the study sponsor, or the study doctors knew which treatment the participant received during the study.[33] The severity of ADHD symptoms observed at the last week of treatment was significantly greater in participants who received placebo compared with participants who received viloxazine.[33] The severity of ADHD symptoms was assessed using the Attention-Deficit Hyperactivity Disorder Rating Scale 5th Edition (ADHD-RS-5).[33] A fourth study provided information about the safety of viloxazine in adolescents 12 to 17 years of age with ADHD.[33] The FDA approved viloxazine based on evidence from several clinical trial(s) of 1289 participants with attention deficit hyperactivity disorder (ADHD).[33] The trials were conducted at 59 sites in the United States.[33]
Society and culture
Brand names
Viloxazine has been marketed under the brand names Emovit, Qelbree, Vicilan, Viloxazin, Viloxazina, Viloxazinum, Vivalan, and Vivarint.[6][34]
Research
Viloxazine has undergone two randomized controlled trials for nocturnal enuresis (bedwetting) in children, both of those times versus imipramine.[35][36] By 1990, it was seen as a less cardiotoxic alternative to imipramine, and to be especially effective in heavy sleepers.[37]
In narcolepsy, viloxazine has been shown to suppress auxiliary symptoms such as cataplexy and also abnormal sleep-onset REM[38] without significantly improving daytime somnolence.[39] In a cross-over trial (56 participants) viloxazine significantly reduced EDS and cataplexy.[14]
Viloxazine has also been studied for the treatment of alcoholism, with some success.[40]
Viloxazine did not demonstrate efficacy in a double-blind randomized controlled trial versus amisulpride in the treatment of dysthymia.[41]
^ abcPinder RM, Brogden RN, Speight TM, Avery GS (June 1977). "Viloxazine: a review of its pharmacological properties and therapeutic efficacy in depressive illness". Drugs. 13 (6): 401–421. doi:10.2165/00003495-197713060-00001. PMID324751. S2CID44804763.
^Case DE, Reeves PR (February 1975). "The disposition and metabolism of I.C.I. 58,834 (viloxazine) in humans". Xenobiotica; the Fate of Foreign Compounds in Biological Systems. 5 (2): 113–129. doi:10.3109/00498257509056097. PMID1154799.
^"SID 180462". PubChem Substance Summary. U.S. National Library of Medicine. Archived from the original on 14 June 2013. Retrieved 5 November 2005.
^ abBushe C, Day K, Reed V, Karlsdotter K, Berggren L, Pitcher A, et al. (May 2016). "A network meta-analysis of atomoxetine and osmotic release oral system methylphenidate in the treatment of attention-deficit/hyperactivity disorder in adult patients". Journal of Psychopharmacology. 30 (5): 444–458. doi:10.1177/0269881116636105. PMID27005307. S2CID104938.{{cite journal}}: CS1 maint: overridden setting (link)
^ abOlivier B, Soudijn W, van Wijngaarden I (2000). "Serotonin, dopamine and norepinephrine transporters in the central nervous system and their inhibitors". Progress in Drug Research. Fortschritte der Arzneimittelforschung. Progres des Recherches Pharmaceutiques. Vol. 54. pp. 59–119. doi:10.1007/978-3-0348-8391-7_3. ISBN978-3-0348-9546-0. PMID10857386.
^ abDahmen MM, Lincoln J, Preskorn S (2010). "NARI Antidepressants". In Stolerman IP (ed.). Encyclopedia of Psychopharmacology. Berlin Heidelberg: Springer-Verlag. pp. 816–822. ISBN9783540687061.
^ abcWilliams DA (2012). "Chapter 18: Antidepressants.". In Lemke TL, Williams DA (eds.). Foye's Principles of Medicinal Chemistry. Lippincott Williams & Wilkins. ISBN9781609133450.
^Chebili S, Abaoub A, Mezouane B, Le Goff JF (1998). "[Antidepressants and sexual stimulation: the correlation]" [Antidepressants and sexual stimulation: the correlation]. L'Encephale (in French). 24 (3): 180–184. PMID9696909.
^Poznanski AJ, Akinyemi E (September 2022). "Recent Advances in Psychopharmacology". Advances in Psychiatry and Behavioral Health. 2 (1): 253–266. doi:10.1016/j.ypsc.2022.03.009. S2CID252258910.
^Perault MC, Griesemann E, Bouquet S, Lavoisy J, Vandel B (September 1989). "A study of the interaction of viloxazine with theophylline". Therapeutic Drug Monitoring. 11 (5): 520–522. doi:10.1097/00007691-198909000-00005. PMID2815226.
^ abTatsumi M, Groshan K, Blakely RD, Richelson E (December 1997). "Pharmacological profile of antidepressants and related compounds at human monoamine transporters". European Journal of Pharmacology. 340 (2–3): 249–258. doi:10.1016/s0014-2999(97)01393-9. PMID9537821.
^Richelson E, Nelson A (July 1984). "Antagonism by antidepressants of neurotransmitter receptors of normal human brain in vitro". The Journal of Pharmacology and Experimental Therapeutics. 230 (1): 94–102. PMID6086881.
^Wander TJ, Nelson A, Okazaki H, Richelson E (December 1986). "Antagonism by antidepressants of serotonin S1 and S2 receptors of normal human brain in vitro". European Journal of Pharmacology. 132 (2–3): 115–121. doi:10.1016/0014-2999(86)90596-0. PMID3816971.
^Danchev ND, Rozhanets VV, Zhmurenko LA, Glozman OM, Zagorevskiĭ VA (May 1984). "[Behavioral and radioreceptor analysis of viloxazine stereoisomers]" [Behavioral and radioreceptor analysis of viloxazine stereoisomers]. Biulleten' Eksperimental'noi Biologii I Meditsiny (in Russian). 97 (5): 576–578. PMID6326891.
^Wermuth CG (2006). "Chapter 1: Analogs as a Means of Discovering New Drugs.". In Fischer J, Ganellin CR (eds.). Analogue-based Drug Discovery. John Wiley & Sons. ISBN978352760749-5.
^Attenburrow AA, Stanley TV, Holland RP (January 1984). "Nocturnal enuresis: a study". The Practitioner. 228 (1387): 99–102. PMID6364124.
^^ Yurdakök M, Kinik E, Güvenç H, Bedük Y (1987). "Viloxazine versus imipramine in the treatment of enuresis". The Turkish Journal of Pediatrics. 29 (4): 227–230. PMID3332732.
^Libert MH (1990). "[The use of viloxazine in the treatment of primary enuresis]" [The use of viloxazine in the treatment of primary enuresis]. Acta Urologica Belgica (in French). 58 (1): 117–122. PMID2371930.
^Altamura AC, Mauri MC, Girardi T, Panetta B (1990). "Alcoholism and depression: a placebo controlled study with viloxazine". International Journal of Clinical Pharmacology Research. 10 (5): 293–298. PMID2079386.
This article relies largely or entirely on a single source. Please help improve this article by introducing citations to additional sources.Find sources: Oskari Vuorivirta – news · newspapers · books · scholar · JSTOR (October 2023) Finnish Lutheran pastor and politician (1861–1923) Oskar (Oskari) Herman Vuorivirta (15 January 1861 – 22 December 1923; surname until 1906 Bergström) was a Finnish Lutheran pastor and politician, born in Sotkamo. He …
Bobby Doerr Doerr in una figurina del 1950 Nazionalità Stati Uniti Baseball Ruolo Seconda base Termine carriera 1951 Hall of fame National Baseball Hall of Fame (1986) Record Batte sinistro Tira destro Debutto in MLB 20 aprile 1937 con i Boston Red Sox Media battuta (AVG) .288 Fuoricampo (HR) 223 Punti battuti a casa (RBI) 1247 CarrieraSquadre di club 1937–1944,1946-1951 Boston Red SoxPalmarès Trofeo Vittorie All-Star 9 Vedi maggiori dettagli Modifica dati su Wikidata&…
توريس حاملاً الحذاء الذهبي في كأس القارات 2013. فرناندو توريس هو لاعب كرة قدم إسباني دولي مثل بلاده 110 مرَّات وسجل 38 هدفاً منذ بدايته في عام 2003 ونهايته في 2014. اعتبارًا من فبراير 2017، أصبح توريس ثالث أكبر هدَّاف في تاريخ المنتخب الوطني، حيث سجل دافيد فيا (59 هدفاً) وراؤول غونزاليس (44…
German krautrock band This article needs additional citations for verification. Please help improve this article by adding citations to reliable sources. Unsourced material may be challenged and removed.Find sources: Faust band – news · newspapers · books · scholar · JSTOR (February 2010) (Learn how and when to remove this message) FaustFaust at Wümme, 1971; back from left: Zappi, Péron, Sosna, Wüsthoff, Irmler, Meifert; front from left: Nettelbec…
حمود بن عبد العزيز آل سعود معلومات شخصية الميلاد سنة 1947 الرياض الوفاة 25 فبراير 1994 (46–47 سنة) الرياض مكان الدفن مقبرة العود مواطنة السعودية الأب عبد العزيز آل سعود إخوة وأخوات البندري بنت عبد العزيز آل سعود، والجوهرة بنت عبد العزيز آل سعود، ولطي…
Place in British Columbia, CanadaLaketon Cassiar CountryLaketonLocation of Laketon in the Cassiar Country in British ColumbiaCoordinates: 58°42′00″N 130°06′00″W / 58.70000°N 130.10000°W / 58.70000; -130.10000Country CanadaProvince British ColumbiaArea code(s)250, 778 The Cassiar Country, also referred to simply as the Cassiar, is a historical geographic region of the Canadian province of British Columbia. The Cassiar is located in the northwest porti…
AlmatyBishkekQabalaBodrumNur-SultanCholpon AtaBakuIstanbulclass=notpageimage| Location of Turkic Council Summits The following lists the Turkic Council Heads of States Summits organized between 2011 and 2021. Prior to 2011, Turkic Speaking States summits were held between 1992 and 2010. Organization of Turkic States Summits are held since 2022. 1st summit First Turkic Council summit was held in Almaty, Kazakhstan on October 21, 2011. The theme was Cooperation in Economic Area and Trade Area.[…
Normal work uniform of the United States Coast Guard A Coast Guardsman wearing the untucked ODU The Operational Dress Uniform (ODU) is the normal work uniform of the United States Coast Guard, the U.S. Coast Guard Auxiliary, the National Oceanic and Atmospheric Administration Commissioned Officer Corps, and the U.S. Public Health Service Commissioned Corps (PHSCC). It is also one of the uniforms worn by the New York Naval Militia.[1] History 2000s The Coast Guard introduced the new Opera…
American publisher and Mennonite leader (1835–1830) Funk, circa 1870-80 John Fretz Funk (April 6, 1835 – January 8, 1930) was a publisher and leader of the Mennonite Church.[1] Funk published the Herald of Truth from 1864 until 1908 when it merged with the Gospel Witness to form the Gospel Herald.[2] Jacob Clemens Kolb, in his preface to Bless the Lord, O My Soul quotes an unnamed commentator who said, John F. Funk is the most important [Mennonite] man after Menno Simons.[…
1942 Japanese general election ← 1937 30 April 1942 1946 → All 466 seats in the House of Representatives234 seats needed for a majority First party Leader Hideki Tojo Party Taisei Yokusankai Last election 421 Seats won 381 Prime Minister before election Hideki Tojo Taisei Yokusankai Prime Minister after election Hideki Tojo Taisei Yokusankai This article is part of a series onPolitics of Japan Constitution and Laws Constitution of Japan (1947–prese…
José Saez Informasi pribadiNama lengkap José SaezTanggal lahir 7 Mei 1982 (umur 42)Tempat lahir Menen, BelgiaTinggi 1,70 m (5 ft 7 in)Posisi bermain GelandangInformasi klubKlub saat ini Valenciennes FCNomor 23Karier senior*Tahun Tim Tampil (Gol)2002–04 Angers SCO 53 (6)2004– Valenciennes FC 178 (11) * Penampilan dan gol di klub senior hanya dihitung dari liga domestik dan akurat per Mei 2011 José Saez (lahir 7 Mei 1982) adalah seorang pemain sepak bola berkewargan…
Untuk kegunaan lain, lihat DK (disambiguasi). Artikel ini membutuhkan rujukan tambahan agar kualitasnya dapat dipastikan. Mohon bantu kami mengembangkan artikel ini dengan cara menambahkan rujukan ke sumber tepercaya. Pernyataan tak bersumber bisa saja dipertentangkan dan dihapus.Cari sumber: .dk – berita · surat kabar · buku · cendekiawan · JSTOR (Agustus 2008) .dkDiperkenalkan14 Juli 1987Jenis TLDDomain tingkat tinggi kode negaraStatusAktifRegistriPunkt…
Hierarchical outline list of articles related to Earth sciences See also: Index of Earth science articles The following outline is provided as an overview of and topical guide to Earth science: Diagram of the structure of the Earth including its atmosphere Earth science – all-embracing term for the sciences related to the planet Earth.[1] It is also known as geoscience, the geosciences or the Earthquake sciences, and is arguably a special case in planetary science, the Earth being …
British naval surgeon and explorer of Australia This article is about the explorer. For other uses, see George Bass (disambiguation). George BassEngraving of Bass from The Naval Pioneers of Australia by Louis Becke and Walter Jeffery, 1899Born(1771-01-30)30 January 1771Sleaford, Lincolnshire, EnglandDisappeared5 February 1803 (aged 32)Last seen before leaving Port Jackson, New South Wales, AustraliaNationalityBritishOccupation(s)Ship's surgeon and explorerSpouseElizabeth Waterhouse George B…
River in Vietnam, and in China Sông Đà redirects here. For the place, see Sông Đà (ward). Black RiverVietnamese: sông Đà Da riverChinese: 李仙江 lǐxiān jiāng Fairy Li' riverLocationCountryVietnamChinaPhysical characteristicsLength910 km (570 mi) Black River near Mường Lay town The Black River, (Vietnamese: Sông Đà, from the Tai language Da meaning dark-brown) also known upstream as the Lixian River in China,[1] is a river located in China and northwest…
Cet article est une ébauche concernant la Mongolie et les Jeux olympiques. Vous pouvez partager vos connaissances en l’améliorant (comment ?) selon les recommandations des projets correspondants. Mongolie aux Jeux olympiques de la jeunesse d'hiver de 2012 Code CIO MGL Comité Comité olympique mongol Site web www.olympic.mn/ Lieu Innsbruck Participation 1re aux Jeux olympiques de la jeunesse d'hiver Athlètes 2 dans 2 sports Porte-drapeau Dandar Usukhbayar[1] MédaillesRang : Or0 A…